Innovations

CAR T cell therapy could reach beyond cancer

0
AI nuclear energy background, future innovation of disruptive technology

Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers. Now, investigators have reported highly promising early results for CAR T therapy in a small set of patients with the autoimmune disease lupus. Penn Medicine CAR T pioneer Carl June, MD, and Daniel Baker, a doctoral student in Cell and Molecular Biology in the Perelman School of Medicine at the University of Pennsylvania, discuss this development in a commentary published today in Cell.

New study on morphine treatment in people with COPD and severe, long term breathlessness

Previous article

Rates of carrying loaded handgun double in 4 years

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations